288.90
price down icon0.03%   -0.1587
 
loading
前日終値:
$289.06
開ける:
$288.25
24時間の取引高:
427.49K
Relative Volume:
0.48
時価総額:
$42.30B
収益:
$5.15B
当期純損益:
$1.40B
株価収益率:
30.38
EPS:
9.51
ネットキャッシュフロー:
$1.65B
1週間 パフォーマンス:
+1.49%
1か月 パフォーマンス:
+10.68%
6か月 パフォーマンス:
+24.72%
1年 パフォーマンス:
+28.83%
1日の値動き範囲:
Value
$286.31
$289.66
1週間の範囲:
Value
$283.15
$290.30
52週間の値動き範囲:
Value
$199.92
$293.08

Resmed Inc Stock (RMD) Company Profile

Name
名前
Resmed Inc
Name
セクター
Healthcare (1161)
Name
電話
(858) 746-2400
Name
住所
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Name
職員
9,980
Name
Twitter
@resmed
Name
次回の収益日
2024-10-24
Name
最新のSEC提出書
Name
RMD's Discussions on Twitter

RMD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Instruments & Supplies icon
RMD
Resmed Inc
288.88 41.89B 5.15B 1.40B 1.65B 9.51
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
470.49 172.53B 9.15B 2.63B 1.99B 7.17
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
198.06 55.89B 21.39B 1.61B 2.55B 5.56
Medical Instruments & Supplies icon
ALC
Alcon Inc
79.01 43.59B 9.93B 1.12B 1.43B 2.26
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
243.91 17.48B 2.96B 487.70M 344.00M 6.68

Resmed Inc Stock (RMD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-15 アップグレード RBC Capital Mkts Sector Perform → Outperform
2025-03-19 開始されました Morgan Stanley Overweight
2025-01-16 開始されました Goldman Buy
2025-01-10 開始されました Piper Sandler Neutral
2024-12-13 開始されました Stifel Hold
2024-09-24 開始されました Robert W. Baird Outperform
2024-09-18 ダウングレード Wolfe Research Peer Perform → Underperform
2024-09-04 ダウングレード Needham Buy → Hold
2024-06-25 ダウングレード Oppenheimer Outperform → Perform
2024-06-24 ダウングレード Citigroup Buy → Neutral
2024-02-06 再開されました KeyBanc Capital Markets Overweight
2023-10-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2023-10-12 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2023-10-09 アップグレード JP Morgan Neutral → Overweight
2023-09-29 ダウングレード Wolfe Research Outperform → Peer Perform
2023-09-06 アップグレード Needham Hold → Buy
2023-09-05 ダウングレード UBS Buy → Neutral
2023-08-01 アップグレード RBC Capital Mkts Sector Perform → Outperform
2023-05-23 開始されました UBS Buy
2023-04-14 開始されました Mizuho Buy
2023-01-17 アップグレード JP Morgan Neutral → Overweight
2022-10-28 ダウングレード Citigroup Buy → Neutral
2022-10-20 アップグレード BofA Securities Neutral → Buy
2022-10-12 開始されました Jefferies Hold
2022-09-08 アップグレード Citigroup Neutral → Buy
2022-08-15 ダウングレード CLSA Buy → Outperform
2022-08-12 ダウングレード Citigroup Buy → Neutral
2022-08-12 ダウングレード JP Morgan Overweight → Neutral
2022-08-12 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2022-06-06 アップグレード RBC Capital Mkts Sector Perform → Outperform
2022-04-06 開始されました Wolfe Research Outperform
2022-01-31 アップグレード Citigroup Neutral → Buy
2022-01-31 アップグレード Goldman Neutral → Buy
2022-01-28 アップグレード RBC Capital Mkts Underperform → Sector Perform
2022-01-24 アップグレード BofA Securities Underperform → Neutral
2022-01-24 アップグレード JP Morgan Neutral → Overweight
2022-01-13 アップグレード CLSA Outperform → Buy
2022-01-13 アップグレード Robert W. Baird Neutral → Outperform
2021-12-21 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2021-12-06 アップグレード Macquarie Neutral → Outperform
2021-10-22 アップグレード CLSA Underperform → Outperform
2021-08-02 ダウングレード CLSA Outperform → Sell
2021-08-02 ダウングレード Needham Buy → Hold
2021-07-28 アップグレード Jefferies Underperform → Hold
2021-07-26 ダウングレード JP Morgan Overweight → Neutral
2021-07-14 開始されました RBC Capital Mkts Underperform
2021-06-28 ダウングレード Citigroup Buy → Neutral
2021-06-22 アップグレード Macquarie Neutral → Outperform
2021-06-22 開始されました Robert W. Baird Neutral
2021-06-21 繰り返されました Needham Buy
2021-06-16 ダウングレード BofA Securities Neutral → Underperform
2021-06-09 アップグレード CLSA Sell → Outperform
2021-05-21 アップグレード JP Morgan Neutral → Overweight
2021-05-11 アップグレード Citigroup Neutral → Buy
2021-04-30 ダウングレード Citigroup Buy → Neutral
2021-03-16 アップグレード Needham Hold → Buy
2020-11-02 アップグレード UBS Neutral → Buy
2020-10-30 アップグレード JP Morgan Underweight → Neutral
2020-10-27 アップグレード BofA Securities Underperform → Neutral
2020-08-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-06-17 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-05-01 ダウングレード JP Morgan Neutral → Underweight
2020-05-01 アップグレード Oppenheimer Perform → Outperform
2020-02-18 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-02-03 開始されました CLSA Underperform
2020-01-31 ダウングレード UBS Buy → Neutral
2020-01-10 開始されました Oppenheimer Perform
2019-11-22 開始されました KeyBanc Capital Markets Sector Weight
2019-07-29 アップグレード UBS Neutral → Buy
2019-07-16 ダウングレード UBS Buy → Neutral
2019-05-06 アップグレード UBS Neutral → Buy
2019-04-18 アップグレード JP Morgan Underweight → Neutral
2019-01-25 ダウングレード Goldman Buy → Neutral
2019-01-25 ダウングレード JP Morgan Neutral → Underweight
2018-10-26 アップグレード Credit Suisse Neutral → Outperform
2018-07-02 開始されました Goldman Buy
すべてを表示

Resmed Inc (RMD) 最新ニュース

pulisher
Aug 20, 2025

ResMed Updates Dividend Exchange Rate for ASX CDI Holders - MSN

Aug 20, 2025
pulisher
Aug 20, 2025

Resmed names new board director - HME News

Aug 20, 2025
pulisher
Aug 20, 2025

Stock Analysis | ResMed OutlookTechnical Weakness Weighs Despite Strong Fundamentals - AInvest

Aug 20, 2025
pulisher
Aug 20, 2025

ResMed up on bullish analyst notes after solid quarter - MSN

Aug 20, 2025
pulisher
Aug 19, 2025

Resmed Director Makes a Significant Stock Sale! - TipRanks

Aug 19, 2025
pulisher
Aug 19, 2025

Buy ResMed and this ASX stock for 10%+ returns - MSN

Aug 19, 2025
pulisher
Aug 19, 2025

Resmed director Hernandez sells $739k in stock - Investing.com

Aug 19, 2025
pulisher
Aug 19, 2025

Resmed Inc Announces Proposed Sale of Securities - TipRanks

Aug 19, 2025
pulisher
Aug 18, 2025

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio - Koreabizwire

Aug 18, 2025
pulisher
Aug 18, 2025

Resmed Elects Nicole Mowad-Nassar to Board of Directors, Announces Retirement of Rich Sulpizio - Quiver Quantitative

Aug 18, 2025
pulisher
Aug 18, 2025

Resmed announces election of Nicole Mowad-Nassar to board, upcoming retirement of Rich Sulpizio - MarketScreener

Aug 18, 2025
pulisher
Aug 18, 2025

Resmed, Inc. - Via Ritzau

Aug 18, 2025
pulisher
Aug 18, 2025

CICC Adjusts Price Target on ResMed to $325 From $295, Maintains Outperform Rating - MarketScreener

Aug 18, 2025
pulisher
Aug 17, 2025

Is ResMed Inc. forming higher highs and higher lowsIndex Update & Target Return Focused Stock Picks - thegnnews.com

Aug 17, 2025
pulisher
Aug 16, 2025

Why ResMed Inc. stock attracts strong analyst attentionWeekly Risk Report & Growth Focused Investment Plans - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Are Resmed CDI (ASX:RMD) shares good value in 2025? - Rask Media

Aug 16, 2025
pulisher
Aug 16, 2025

What’s the analyst consensus on ResMed Inc.July 2025 Trade Ideas & Verified Technical Signals - newsyoung.net

Aug 16, 2025
pulisher
Aug 15, 2025

ResMed Gains 0.06% as $290M Volume Ranks 357th Mixed Institutional and Analyst Signals Fuel Market Uncertainty - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

22% Of This ResMed Insider's Holdings Were Sold - 富途牛牛

Aug 15, 2025
pulisher
Aug 14, 2025

ResMed Shares Dip 1.23% as Daily Volume Ranks 381st Amid Market Volatility - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

ResMed’s (RMD) Dividend Hike and Buybacks Could Be a Game Changer for Investor Sentiment - simplywall.st

Aug 14, 2025
pulisher
Aug 14, 2025

ResMed Inc. Price Targets Raised After Rebound2025 Major Catalysts & Safe Entry Momentum Tips - beatles.ru

Aug 14, 2025
pulisher
Aug 13, 2025

ResMed Inc.’s Price Action Aligns with Quant SignalsJuly 2025 Opening Moves & AI Driven Price Forecasts - sundaytimes.kr

Aug 13, 2025
pulisher
Aug 13, 2025

Sector Leaders Rotate Capital Into ResMed Inc.Portfolio Risk Report & Accurate Entry/Exit Alerts - 선데이타임즈

Aug 13, 2025
pulisher
Aug 13, 2025

Why ResMed (RMD) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

The Top 5 Analyst Questions From ResMed’s Q2 Earnings Call - Yahoo Finance

Aug 13, 2025
pulisher
Aug 12, 2025

Can ResMed Inc. disrupt its industryLow Risk High Return Picks - thegnnews.com

Aug 12, 2025
pulisher
Aug 12, 2025

Ex-Dividend Reminder: WEC Energy Group, UNITIL and ResMed - Nasdaq

Aug 12, 2025
pulisher
Aug 12, 2025

Are Bears Losing Grip on ResMed Inc.Entry Zone Strategy for Consistent Profit Shared - beatles.ru

Aug 12, 2025
pulisher
Aug 12, 2025

Why ResMed (RMD) is a Top Growth Stock for the Long-Term - sharewise.com

Aug 12, 2025
pulisher
Aug 11, 2025

ResMed Rises to 432nd in Market Activity Amid 13.1% Earnings Growth Outlook and $0.24 Billion Volume - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Here's How Much You'd Have If You Invested $1000 in ResMed a Decade Ago - MSN

Aug 11, 2025
pulisher
Aug 11, 2025

ResMed Insider Sold Shares Worth $2,238,379, According to a Recent SEC Filing - MarketScreener

Aug 11, 2025
pulisher
Aug 11, 2025

Resmed Earnings Up 10% in FY2025 - San Diego Business Journal

Aug 11, 2025
pulisher
Aug 11, 2025

ResMed Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance

Aug 11, 2025
pulisher
Aug 11, 2025

Is ResMed's (RMD) Dividend Hike and Leadership Change Shaping Its Capital Allocation Strategy? - simplywall.st

Aug 11, 2025
pulisher
Aug 10, 2025

Dividend Information on ResMed: Essential Details Before the Ex-Dividend Date on Aug 14, 2025 - AInvest

Aug 10, 2025
pulisher
Aug 09, 2025

ResMed: Accelerating Global Expansion With Strong Growth in Europe & China! - Smartkarma

Aug 09, 2025
pulisher
Aug 08, 2025

ResMed’s 419th High-Volume Rank Drives 166.71% Gains as Liquidity-Driven Strategy Surpasses Benchmark - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

RESMED INC SEC 10-K Report - TradingView

Aug 08, 2025
pulisher
Aug 07, 2025

ResMed CEO Sells Shares - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

ResMed Inc. Reports Change in Beneficial Ownership - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

ResMed CFO Adjusts Stock Holdings in Routine Transaction - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

ResMed Ranks 453rd in $260M Volume as Institutional Buys and Earnings Beat Fuel Analyst Price Hikes - AInvest

Aug 07, 2025
pulisher
Aug 06, 2025

Macro Intelligence: ResMed breathes easy with FY2025 financial growth - ig.com

Aug 06, 2025
pulisher
Aug 06, 2025

ResMed Stock Slides on 39.59% Volume Drop to $280M Ranks 425th as Analysts Hike Targets to $290-$325 Amid Strong Earnings and Dividend Boost - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

ResMed is an ASX share market success story that deserves your attention - MSN

Aug 06, 2025
pulisher
Aug 06, 2025

Morgans Maintains Buy Rating for Resmed Inc with Price Target of A$47.86 - AInvest

Aug 06, 2025
pulisher
Aug 05, 2025

Resmed Inc Reports Increase in CHESS Depositary Interests - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

ResMed Inc Announces Proposed Sale of Common Shares - MSN

Aug 05, 2025

Resmed Inc (RMD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_instruments_supplies ALC
$79.07
price down icon 2.33%
medical_instruments_supplies BDX
$198.15
price down icon 0.51%
medical_instruments_supplies WST
$243.77
price down icon 0.97%
$67.83
price down icon 1.37%
medical_instruments_supplies COO
$73.44
price down icon 0.10%
大文字化:     |  ボリューム (24 時間):